General Obstetrics and Gynecology: Obstetrics| Volume 193, ISSUE 1, P153-163, July 2005

Download started.


Therapy with both magnesium sulfate and nifedipine does not increase the risk of serious magnesium-related maternal side effects in women with preeclampsia


      Does the use of nifedipine and magnesium sulfate together increase serious magnesium-related effects?

      Study design

      This was a retrospective chart review of women who were admitted to BC Women's Hospital and Health Centre (1997-2001) and were given intravenous magnesium sulfate for preeclampsia. Serious magnesium-related effects were compared among 162 cases who received magnesium sulfate and contemporaneous nifedipine and 215 control subjects who received magnesium sulfate and either another antihypertensive (n = 32 women) or no antihypertensive (n = 183 women) medication. Chi-squared test, Fisher's exact test, or the Student t test was used for data comparison between cases and each control group. A probability value of <.05 was considered statistically significant.


      The cases had more severe preeclampsia and a longer magnesium sulfate infusion. However, cases had no excess of neuromuscular weakness (53.1%) versus control subjects who received antihypertensive medication (53.1%; P = .99) or control subjects who received no antihypertensive medication (44.8%; P = .13) or other serious magnesium-related effects. Cases versus control subjects who received antihypertensive medication had less neuromuscular blockade (odds ratio, 0.04; 95% CI, 0.002-0.80). Cases versus control subjects who received no antihypertensive medication had less maternal hypotension (41.4% vs 53.0%; P = .04).


      The use of nifedipine and magnesium sulfate together does not increase the risk of serious magnesium-related effects.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Obstetrics & Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Rey E.
        • LeLorier J.
        • Burgess E.
        • Lange I.R.
        • Leduc L.
        Report of the Canadian Hypertension Society Consensus Conference: 3, pharmacologic treatment of hypertensive disorders in pregnancy.
        CMAJ. 1997; 157: 1245-1254
        • Brown M.A.
        • Hague W.M.
        • Higgins J.
        • Lowe S.
        • McCowan L.
        • Oats J.
        • et al.
        The detection, investigation and management of hypertension in pregnancy: executive summary.
        Aust N Z J Obstet Gynaecol. 2000; 40: 133-138
      1. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy.
        Am J Obstet Gynecol. 2000; 183: S1-S22
        • Ben Ami M.
        • Giladi Y.
        • Shalev E.
        The combination of magnesium sulphate and nifedipine: a cause of neuromuscular blockade.
        Br J Obstet Gynaecol. 1994; 101: 262-263
        • Snyder S.W.
        • Cardwell M.S.
        Neuromuscular blockade with magnesium-sulfate and nifedipine.
        Am J Obstet Gynecol. 1989; 161: 35-36
        • Impey L.
        Severe hypotension and fetal distress following sublingual administration of nifedipine to a patient with severe pregnancy induced hypertension at 33 weeks.
        BJOG. 1993; 100: 959-961
        • Waisman G.D.
        • Mayorga L.M.
        • Camera M.I.
        • Vignolo C.A.
        • Martinotti A.
        Magnesium plus nifedipine: Potentiation of hypotensive effect in preeclampsia?.
        Am J Obstet Gynecol. 1988; 159: 308-309
        • Magee L.A.
        • Ornstein M.P.
        • von Dadelszen P.
        Fortnightly review: management of hypertension in pregnancy.
        BMJ. 1999; 318: 1332-1336
        • Magee L.A.
        • Cham C.
        • Waterman E.J.
        • Ohlsson A.
        • von Dadelszen P.
        Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis.
        BMJ. 2003; 327: 955-960
        • Messerli F.H.
        • Grossman E.
        The calcium antagonist controversy: a posthumous commentary.
        Am J Cardiol. 1998; 82: 35R-39R
        • Magee L.A.
        • von Dadelszen P.
        • Bohun C.M.
        • Rey E.
        • El Zibdeh M.
        • Stalker S.
        • et al.
        Serious perinatal complications of non-proteinuric hypertension: an international, multicentre, retrospective cohort study.
        J Obstet Gynaecol Can. 2003; 25: 372-382
      2. Why mothers die 1997-1999: the confidential enquiries into maternal deaths in the UK.
        RCOG Press, London2001
        • Duley L.
        • Farrell B.
        • Spark P.
        • Roberts B.
        • Watkins K.
        • Bricker L.
        • et al.
        Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial.
        Lancet. 2002; 359: 1877-1890
        • Helewa M.E.
        • Burrows R.F.
        • Smith J.
        • Williams K.
        • Brain P.
        • Rabkin S.W.
        Report of the Canadian Hypertension Society Consensus Conference: 1, definitions, evaluation and classification of hypertensive disorders in pregnancy.
        CMAJ. 1997; 157: 715-725
        • Aali B.S.
        • Nejad S.S.
        Nifedipine or hydralazine as a first-line agent to control hypertension in severe preeclampsia.
        Acta Obstetricia et Gynecologica Scand. 2002; 81: 25-30
        • Elatrous S.
        • Nouira S.
        • Besbes L.O.
        • Marghli S.
        • Boussarssar M.
        • Sakkouhi M.
        • et al.
        Short-term treatment of severe hypertension of pregnancy: prospective comparison of nicardipine and labetalol.
        Intens Care Med. 2002; 28: 1281-1286
        • Fenakel K.
        • Fenakel G.
        • Appelman Z.
        • Lurie S.
        • Katz Z.
        • Shoham Z.
        Nifedipine in the treatment of severe preeclampsia.
        Obstet Gynecol. 1991; 77: 331-337
        • Kwawukume E.Y.
        • Ghosh T.S.
        Oral nifedipine therapy in the management of severe preeclampsia.
        Int J Gynaecol Obstet. 1995; 49: 265-269
        • Martins-Costa S.
        • Ramos J.G.
        • Barros E.
        • Bruno R.M.
        • Costa C.A.
        • Goldin J.R.
        Randomized, controlled trial of hydralazine versus nifedipine in preeclamptic women with acute hypertension.
        Clin Exper Hypertens Pregn. 1992; B11: 25-44
        • Vermillion S.T.
        • Scardo J.A.
        • Newman R.B.
        • Chauhan S.P.
        A Randomized, double-blind trial of oral nifedipine and intravenous labetalol in hypertensive emergencies of pregnancy.
        Am J Obstet Gynecol. 1999; 181: 858-861
        • Jegasothy R.
        • Paranthaman S.
        Sublingual nifedipine compared with intravenous hydralazine in the acute treatment of severe hypertension in pregnancy: potential for use in rural practice.
        J Obstet Gynaecol Res. 1996; 22: 21-24
        • Seabe S.J.
        • Moodley J.
        • Becker P.
        Nifedipine in acute hypertensive emergencies in pregnancy.
        S Afr Med J. 1989; 76: 248-250
        • Walss Rodriguez R.J.
        • Amaya L.A.H.
        Pre-eclampsia severa: nifedipina versus cloropromazina en el manejo del estado hipertensivo agudo.
        Rev Med IMSS. 1989; 27: 359-363
        • Duggan P.M.
        • McCowan L.M.
        • Stewart A.W.
        Antihypertensive drug effects on placental flow velocity waveforms in pregnant women with severe hypertension.
        Aust N Z J Obstet. Gynaecol. 1992; 32: 335-338
        • Maharaj B.
        • Khedun S.M.
        • Moodley J.
        • van der Byl K.
        • Rapiti N.
        A comparative study of intravenous isradipine and dihydralazine in the treatment of severe hypertension of pregnancy in black patients.
        Hypertens Pregn. 1997; 16: 1-9
        • Walss Rodriguez R.J.
        • Padilla L.M.F.
        Manejo de la preeclampsia severa/eclampsia. comparacion entre nifedipine e hidralazina como medicamentos antihipertensivos.
        Ginec Obst Mex. 1993; 61: 76-79